Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,238.00    -18.00 (-1.43%)
Bid:
1,238.00
Ask:
1,242.00
Spread: 4.00 (0.323%)
Market Cap: £567.33m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

7 Nov 2016 07:00

RNS Number : 4324O
Cohort PLC
07 November 2016
 

Cohort plc

("Cohort")

 

Contract Win

 

SEA secures contracts to supply traffic enforcement systems to TfL

 

Cohort, the independent technology group, is pleased to announce that its subsidiary SEA has been awarded contracts by Transport for London (TfL) to further develop and provide ongoing support of its Digital Traffic Enforcement System (DTES) and to develop and support a Parking Enforcement Solution (PES) mobile application.

 

The combined orders are valued at approximately £7m and include 10 years' of support for both systems. SEA originally developed the DTES system on behalf of TfL. DTES entered into service in 2009 and SEA has provided support over the entire period.

 

Andy Thomis, Chief Executive of Cohort, said:

 

"I am delighted that SEA continues to be involved in this important TfL programme. The addition of the PES system to work with DTES is an exciting development.

 

"This adds further visibility to our order book, which underpins a significant proportion of revenues for Cohort's current financial year."

 

Ends

This announcement includes inside information.

 

For further information please contact:

 

 

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

 

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Jamie Ricketts / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through five market-facing subsidiary companies:

MASS - a specialist systems house with a focus on electronic warfare operational support, cyber defence and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in sourcing, design and integration of surveillance and other electronic systems, as well as field support and training for the UK MOD and other government agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, providing a range of services, including independent technical evaluation of military aircraft safety, and design and delivery of large and small scale military training exercises. Owned by Cohort since flotation in March 2006;

SEA - an advanced systems and software business operating in the defence (naval systems, simulation, training and technology research), transport and offshore energy market sectors. Acquired by Cohort in October 2007.

EID - a Portugal based supplier of advanced electronics, communications and command and control products and systems for the global defence market, in which Cohort acquired a majority stake in June 2016.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTAKQDBOBDDQDK
Date   Source Headline
5th Dec 20237:00 amRNSContract Win
1st Dec 20239:55 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSNotice of Half Year Results
6th Nov 202310:21 amRNSHolding(s) in Company
3rd Nov 202310:35 amRNSHolding(s) in Company
1st Nov 202310:03 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSSHARES/AJ BELL IN-PERSON INVESTOR EVENT NEXT WEEK
16th Oct 20237:00 amRNSShares/AJ Bell Live Investor Event, October 25
13th Oct 20234:03 pmRNSDirector/PDMR Shareholding
6th Oct 20233:48 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:09 pmRNSBlock listing six monthly return
2nd Oct 20231:04 pmRNSTotal Voting Rights
29th Sep 202310:18 amRNSDirector/PDMR Shareholding
26th Sep 20235:00 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Statement & First Quarter Update
21st Sep 20233:45 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSTotal Voting Rights
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.